Icure Pharmaceutical Incorporation Cash Flow Reinvestment Rate
Icure Pharmaceutical Incorporation cash flow reinvestment rate. Icure Pharmaceutical Incorporation (175250) has a Cash Flow Reinvestment Rate of 83.70x as of June 2020, reinvesting ₩16.36 Billion (capex ₩7.44 Billion plus investments ₩8.92 Billion) from operating cash flow of ₩195.44 Million. Explore debt repayment capacity of Icure Pharmaceutical Incorporation to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Icure Pharmaceutical Incorporation (2017–2017)
Cash flow reinvestment rate of Icure Pharmaceutical Incorporation from 2017 to 2017. Historical reinvestment intensity for Icure Pharmaceutical Incorporation across 1 annual periods. Explore 175250 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Icure Pharmaceutical Incorporation Cash Flow Reinvestment Rate by Year (2017–2017)
Icure Pharmaceutical Incorporation cash flow reinvestment rate by year from 2017 to 2017. Year-by-year capital reinvestment analysis for Icure Pharmaceutical Incorporation. For the full cash flow conversion analysis, see Icure Pharmaceutical Incorporation cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 9.20x | ₩10.30 Billion | ₩1.12 Billion | ₩10.10 Billion | — |